Drugs / NOVOCART® Inject plus
last change Feb 2024 re-read 3 minutes ago

NOVOCART® Inject plus

Developed for
osteoarthritis, knee
Investigated by
Tetec AG

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03319797 Oct 2017 → Feb 2021 osteoarthritis, knee Tetec AG Completed Met primary

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NOVOCART Inject plus ClinicalTrials.gov intervention name — accepted as the source's own label NCT03319797 ↗